Search results for "HIV infection"

showing 10 items of 314 documents

The external domains of the HIV-1 envelope are a mutational cold spot

2015

In RNA viruses, mutations occur fast and have large fitness effects. While this affords remarkable adaptability, it can also endanger viral survival due to the accumulation of deleterious mutations. How RNA viruses reconcile these two opposed facets of mutation is still unknown. Here we show that, in human immunodeficiency virus (HIV-1), spontaneous mutations are not randomly located along the viral genome. We find that the viral mutation rate experiences a threefold reduction in the region encoding the most external domains of the viral envelope, which are strongly targeted by neutralizing antibodies. This contrasts with the hypermutation mechanisms deployed by other, more slowly mutating …

Mutation ratevirusesGeneral Physics and AstronomyHIV InfectionsBiologymedicine.disease_causeArticleGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesCytidine deaminationMutation RateViral Envelope ProteinsViral envelopeViral entrymedicineViral structural proteinHumans030304 developmental biologyGenetics0303 health sciencesMutationMultidisciplinary030302 biochemistry & molecular biologyRNAGeneral ChemistryVirologyProtein Structure Tertiary3. Good healthViral evolutionHIV-1Nature Communications
researchProduct

A Prognostic Model for Estimating the Time to Virologic Failure in HIV-1 Infected Patients Undergoing a New Combination Antiretroviral Therapy Regimen

2011

Abstract Background HIV-1 genotypic susceptibility scores (GSSs) were proven to be significant prognostic factors of fixed time-point virologic outcomes after combination antiretroviral therapy (cART) switch/initiation. However, their relative-hazard for the time to virologic failure has not been thoroughly investigated, and an expert system that is able to predict how long a new cART regimen will remain effective has never been designed. Methods We analyzed patients of the Italian ARCA cohort starting a new cART from 1999 onwards either after virologic failure or as treatment-naïve. The time to virologic failure was the endpoint, from the 90th day after treatment start, defined as the firs…

OncologyMaleAdult; Anti-HIV Agents; Cohort Studies; Drug Therapy Combination; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Proportional Hazards Models; Treatment Failure; Viral LoadHIV InfectionsCohort Studies0302 clinical medicineANTIRETROVIRAL THERAPYMedicineHIV Infection030212 general & internal medicineTreatment Failure0303 health sciencesHealth PolicyMiddle AgedViral Load3. Good healthComputer Science ApplicationsCensoring (clinical trials)CohortCombinationlcsh:R858-859.7Drug Therapy CombinationFemaleViral loadHumanResearch ArticleCartAdultmedicine.medical_specialtyAnti-HIV AgentsHIV-1; antiretroviral therapyHealth InformaticsSettore MED/17 - MALATTIE INFETTIVElcsh:Computer applications to medicine. Medical informatics03 medical and health sciencesDrug TherapyInternal medicineHumansSurvival analysisProportional Hazards Models030306 microbiologybusiness.industryProportional hazards modelAdult; Anti-HIV Agents; Cohort Studies; Drug Therapy Combination; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Proportional Hazards Models; Treatment Failure; Viral Load; Health Informatics; Health PolicyANTIRETROVIRAL DRUGSAnti-HIV AgentHIVGENOTYPESDiscontinuationRegimenImmunologyProportional Hazards ModelHIV-1Cohort StudiebusinessBMC Medical Informatics and Decision Making
researchProduct

Differential Effects of Tenofovir/Emtricitabine and Abacavir/Lamivudine on Human Leukocyte Recruitment

2012

Background The association of abacavir (ABC) with cardiovascular disease has led to HIV treatment guidelines favouring the combination of tenofovir/emtricitabine (TDF/FTC) over that of ABC/lamivudine (ABC/3TC). We have analysed the effects of plasma-relevant concentrations of TDF, FTC, ABC and 3TC, individually and in clinically employed combinations, on human leukocyte accumulation. The effects of ABC, 3TC, TDF and FTC on the expression of adhesion molecules were also evaluated. Methods Interactions between human leukocytes – specifically peripheral blood polymorphonuclear or mono-nuclear cells – and human umbilical vein endothelial cells were evaluated in a flow chamber reproducing in viv…

OrganophosphonatesHIV InfectionsCD18Cell CommunicationPharmacologyEmtricitabineDeoxycytidinePeripheral blood mononuclear cellIn vivoAbacavirAntiretroviral Therapy Highly ActiveCell AdhesionLeukocytesmedicineEmtricitabineHumansPharmacology (medical)TenofovirPharmacologyCell adhesion moleculebusiness.industryAdenineEndothelial CellsLamivudineAbacavir/LamivudineDideoxynucleosidesDrug CombinationsInfectious DiseasesLamivudinebusinessCell Adhesion Moleculesmedicine.drugAntiviral Therapy
researchProduct

Detection of Human Immunodeficiency Virus-1 Nucleic Acid on Inactivated Filter Paper Disks by Polymerase Chain Reaction and Microtiter Plate Assay

1994

Human immunodeficiency virus type 1 (HIV-1) in cultured cells, peripheral blood samples and sera were adsorbed on filter paper disks and inactivated by heat or ethanol. Two procedures, the polymerase chain reaction (PCR) and microtiter plate assay (HMPA) were used to detect the nucleic acid. The sensitivity after different heat treatments with nested PCR for HIV-1 DNA (or nested reverse transcription-PCR for HIV-1 RNA) was identical regardless of whether the samples were examined immediately or one month later. Inactivation by ethanol treatment resulted in a slight loss of sensitivity. The HMPA proved to be as reliable and specific as the conventional PCR technique. We conclude that the hea…

PaperHot TemperatureMolecular Sequence DataImmunologyHIV InfectionsBiologyPolymerase Chain ReactionSensitivity and SpecificityMicrobiologyViruslaw.inventionImmunoenzyme Techniqueschemistry.chemical_compoundMicrotiter platelawVirologyHumansFalse Positive ReactionsCells CulturedPolymerase chain reactionBase SequenceFilter paperRNAGenes gagMolecular biologychemistryDNA ViralHIV-1Nucleic acidRNA ViralNested polymerase chain reactionFiltrationDNAMicrobiology and Immunology
researchProduct

Different methods of cell quantification can lead to different results: a comparison of digital methods using a pilot study of dendritic cells in HIV…

2019

Background Although new digital pathology tools have improved the positive cell quantification, there is a heterogeneity of the quantification methods in the literature. The aim of this study was to evaluate and propose a novel dendritic cells quantification method in squamous cell carcinoma comparing it with a conventional quantification method. Material and Methods Twenty-six squamous cell carcinomas HIV-positive cases affecting the oropharynx, lips and oral cavity were selected. Immunohistochemistry for CD1a, CD83, and CD207 was performed. The immunohistochemical stains were evaluated by automated examination using a positive pixel count algorithm. A conventional quantification method (u…

Pathologymedicine.medical_specialtyCellHIV InfectionsPilot Projects03 medical and health sciences0302 clinical medicineCarcinomamedicineHumansStage (cooking)General DentistryReproducibilityOral Medicine and Pathologybusiness.industryResearchReproducibility of ResultsDigital pathologyDendritic Cells030206 dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCell countingmedicine.anatomical_structureOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASCarcinoma Squamous CellMann–Whitney U testImmunohistochemistrySurgerybusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Global, regional, and national levels and causes of maternal mortality during 1990-2013: A systematic analysis for the Global Burden of Disease Study…

2014

BACKGROUND: The fifth Millennium Development Goal (MDG 5) established the goal of a 75% reduction in the maternal mortality ratio (MMR; number of maternal deaths per 100,000 livebirths) between 1990 and 2015. We aimed to measure levels and track trends in maternal mortality, the key causes contributing to maternal death, and timing of maternal death with respect to delivery.METHODS: We used robust statistical methods including the Cause of Death Ensemble model (CODEm) to analyse a database of data for 7065 site-years and estimate the number of maternal deaths from all causes in 188 countries between 1990 and 2013. We estimated the number of pregnancy-related deaths caused by HIV on the basi…

PediatricsTime FactorsNutrition and Diseasehiv-infectionimmunodeficiency virus-1 infectionperipartum cardiomyopathyPoison controlHIV InfectionsIMMUNODEFICIENCY VIRUS-1 INFECTIONSocioeconomic FactorGlobal Health0302 clinical medicinePERIPARTUM CARDIOMYOPATHYpregnancy-related mortalityRisk FactorsPregnancyVoeding en ZiekteCause of DeathGlobal healthHIV Infection030212 general & internal medicinePregnancy Complications Infectious10. No inequalityCause of death030219 obstetrics & reproductive medicinesouth-africaMedicine (all)1. No povertyWOMENPREGNANCY-RELATED MORTALITYhealth initiativesGeneral MedicineSOUTH-AFRICA3. Good healthMaternal MortalityWorld HealthCHILD SURVIVALFemaleMaternal deathwomenHumanmedicine.medical_specialtyTime FactorDEATHSchild survivalArticleadult mortality03 medical and health sciencesAge DistributionHEALTH INITIATIVESSDG 3 - Good Health and Well-beingHIV-INFECTIONADULT MORTALITYInjury preventionmedicineOrganizational ObjectivesOrganizational ObjectiveHumansVLAGPregnancyModels Statisticalbusiness.industryRisk Factormedicine.diseasedeathsStandardized mortality ratioSocioeconomic FactorsRelative riskPregnancy Complications InfectioubusinessDemography
researchProduct

Factors Associated with Nonsuppression of HIV Infection in the Spanish VACH Cohort.

2020

We aim to determine the prevalence of HIV nonsuppression and factors associated with it. This is a cross-sectional multicenter study carried out in January 2016 with data of the VACH Cohort, a registry participated by 23 hospitals from most regions of Spain. The prevalence of HIV nonsuppression, defined as HIV RNA ≥200 copies/mL, is documented. The possible association of HIV nonsuppression with sociodemographic and clinical variables is assessed with a logistic regression analysis. A total of 30,843 adult patients are included; 7,358 of them (23.86%) have nonsuppressed HIV. An association is found between nonsuppression of HIV and the following variables: lower body mass index, lower age o…

Pediatricsmedicine.medical_specialtybusiness.industryCoinfectionImmunologyHuman immunodeficiency virus (HIV)HIV InfectionsViral Loadmedicine.disease_causeCD4 Lymphocyte CountInfectious DiseasesCross-Sectional StudiesMulticenter studyAnti-Retroviral AgentsRisk FactorsVirologyChild PreschoolCohortMedicineHumansbusinessAIDS research and human retroviruses
researchProduct

Pepstatins: Aspartic proteinase inhibitors having potential therapeutic applications

1993

Cathepsin D (EC 3.4.23.5) is a lysomal aspartie proteinase that is involved, under normal phusiologycal conditions, ...

Pepstatin AProteinase inhibitorCathepsin DHIV InfectionsPharmacologyCathepsin Dchemistry.chemical_compoundMiceDrug DiscoveryPepstatinsAnimalsHumanscancerPharmacologychemistry.chemical_classificationbiologylysosomal proteinasesBacterial InfectionsNeoplasms ExperimentalMuscular Dystrophy AnimalCathepsinsRatsEnzymechemistryBiochemistryEnzyme inhibitorbiology.proteinMolecular MedicineProteinase inhibitorPepstatin
researchProduct

Recent advances on HIV DNA vaccines development: Stepwise improvements to clinical trials.

2019

According to WHO (World Health Organization) reports, more than 770,000 people died from HIV and almost 1.7 million people becoming newly infected in the worldwide in 2018. Therefore, many attempts should be done to produce a forceful vaccine to control the AIDS. DNA-based vaccines have been investigated for HIV vaccination by researches during the recent 20 years. The DNA vaccines are novel approach for induction of both type of immune responses (cellular and humoral) in the host cells and have many advantages including high stability, fast and easy of fabrication and absence of severe side effects when compared with other vaccination methods. Recent studies have been focused on vaccine de…

Pharmaceutical ScienceHIV Infections02 engineering and technologyVirusDNA vaccination03 medical and health sciencesImmune systemAcquired immunodeficiency syndrome (AIDS)AntigenAdjuvants ImmunologicmedicineVaccines DNAAnimalsHumansVector (molecular biology)030304 developmental biologyAIDS Vaccines0303 health sciencesClinical Trials as TopicImmunity Cellularbusiness.industryVaccination021001 nanoscience & nanotechnologymedicine.diseaseImmunity HumoralVaccinationClinical trialImmunology0210 nano-technologybusinessJournal of controlled release : official journal of the Controlled Release Society
researchProduct

Monocyte to lymphocyte blood ratio in tuberculosis and HIV patients: Comparative analysis, preliminary data

2017

Recent data confirmed the hypothesis suggested by historical studies that the ratio of peripheral blood monocytes to lymphocytes (M/L) is associated with the risk of tuberculosis (TB) disease. We retrospectively analyzed the electronic health records of tuberculosis and HIV-positive patients who had followed day-care programs at the AIDS Center of the University of Palermo, Italy. 261 patients were recruited and divided into 6 groups as follows: healthy control group (HCG: 47 pts), latent HIV negative infected TB group (LIG, 43 pts), active HIV negative tuberculosis (TAG: 61 pts), treated tuberculosis HIV negative (TTG: 44 pts), HIV drug-naive patients tested TST and QFT-IT-negative with ne…

PharmacologyCo-infected HIV/TBCTuberculosiDrug Discovery3003 Pharmaceutical ScienceCo-infected HIV/TBC; HIV infection; Monocyte to lymphocyte blood RATIO; Tuberculosis; Pharmacology; Drug Discovery3003 Pharmaceutical ScienceMonocyte to lymphocyte blood RATIOHIV infection
researchProduct